content

RedHill Biopharma Reports Top-Line Data from Opaganib Phase 2/3 Study in Severe COVID-19 Patients

RedHill Biopharma Ltd. , a specialty biopharmaceutical company, announced preliminary top-line data from the 475-patient global Phase 2/3 study with opaganib (ABC294640) in hospitalized...

Glenmark completes PMS study of Covid-19 drug Favipiravir

Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFluยฎ) in India....

EUA for Lilly’s bamlanivimab and etesevimab administered together expanded to include post-exposure prophylaxis for COVID-19

The U.S. FDAhas expanded the Emergency Use Authorization (EUA) for bamlanivimab 700 mg and etesevimab 1400 mg administered together to include post-exposure prophylaxis (PEP)...

Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance

Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum Institute of India...

Pharmapack Europe: Innovation, Networking and Education

Welcome to Pharmapack Europe 2021! It is an extremely exciting time for the pharmaceutical drug delivery and packaging industry as we emerge from the pandemic...

LANXESS India wins big at the Indian Chemical Council awards

Specialty chemicals company LANXESS India has been conferred with three prestigious awards from the Indian Chemical Council (ICC), recognizing the organizationโ€™s commitment and outstanding...

BMG Pharma and HTL sign a development agreement to manufacture BMG’s new biopolymer based on the Hyaluromimethic Technology

BMG Pharma โ€“ a biotech and B2B company headquartered in Milan with its chemical plant in Torviscosa (Italy) that exports its medical products to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read